市場調査レポート
商品コード
1451865
下垂足用インプラント市場レポート:製品、エンドユーザー、地域別、2024-2032Foot Drop Implants Market Report by Product (Functional Electrical Stimulators, Internal Fixation Devices), End User (Hospitals, Palliative Care Centers, Orthopedic Centers, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
下垂足用インプラント市場レポート:製品、エンドユーザー、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
世界の下垂足用インプラント市場規模は2023年に40億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに72億米ドルに達し、2024年から2032年の間に6.46%の成長率(CAGR)を示すと予測しています。足部落下や神経疾患の有病率の上昇、高齢者人口の拡大、個別化治療ソリューションに対する需要の高まり、インプラントの設計や材料における技術的進歩などが、市場を牽引する主な要因となっています。
下垂足とは、前足部の挙上困難を特徴とする神経学的障害を指します。通常、総腓骨神経の損傷、足首や足の動きをコントロールする筋肉の衰えや麻痺、脳卒中、多発性硬化症、脳性麻痺などの怪我や疾患が原因で起こる。正常な歩行が困難になったり、逸脱したりすることがあり、一般的にステップ歩行や背屈などの症状を伴います。足部脱落インプラントは、損傷部位を置換または補強することで、この症状による機能的制限を軽減するように設計された医療機器です。足首と足に安定性と支持を与えることで、患者は生活の質を向上させながら、可動性を取り戻し、日常生活を容易に行えるようになります。その結果、食品落下インプラントは、患者の機能を回復し、より自然な歩行を促進するため、ヘルスケア業界全体で絶大な人気を集めています。
神経損傷、スポーツ関連傷害、交通事故などの症例増加に起因する足部落下の有病率の上昇は、市場成長を支える主な要因の1つです。さらに、この症状を発症しやすい老年人口の拡大が、世界中で足部落下インプラントの需要増につながっています。さらに、回復期間が短く、傷跡や切開が少なく、合併症のリスクが低減されることから、足部低下の治療には低侵襲(MI)外科手術への移行が著しいです。これに伴い、直接的な機械的支持を提供し筋機能を回復させるための外科的足部落下インプラントの利用が増加しており、製品の採用率が加速しています。さらに、大手メーカーは、より優れた安定性、支持性、快適性、使いやすさを提供する新しいインプラントの発売にも注力しています。このような製品の革新は、患者の転帰と満足度を向上させ、市場の成長を促進しています。これに加えて、有利な償還政策が容易に利用できること、個別化された治療オプションに対する需要が高まっていることも、市場の成長を後押ししています。神経疾患の増加、医療インフラの改善、医療費の増加、インプラントの設計や材料における技術的進歩、進行中の研究開発(R&D)活動などのその他の要因も、今後数年間の市場開拓に拍車をかけると予想されます。
The global foot drop implants market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.46% during 2024-2032. The rising prevalence of foot drop and neurological disorders, expanding geriatric population, escalating demand for personalized treatment solutions, and technological advancements in implant design and materials represent some of the key factors driving the market.
Foot drop refers to a neurological disorder characterized by the dropping of the forefoot or difficulty in lifting the front part of the foot. It usually occurs due to damage to the common fibular nerve, weakness or paralysis of the muscles that control the ankle and foot movement, or injuries and conditions such as stroke, multiple sclerosis, and cerebral palsy. It can lead to difficulty or deviation from normal walking and is commonly associated with symptoms such as steppage gait and dorsiflexion. Foot drop implants are medical devices designed to reduce the functional limitations caused by this condition by replacing or reinforcing the damaged part. They provide stability and support to the ankle and foot, allowing patients to regain mobility and perform daily activities easily while improving the quality of their lives. As a result, food drop implants are gaining immense popularity across the healthcare industry for restoring function and facilitating a more natural gait in patients.
The rising prevalence of foot drop owing to the increasing cases of nerve damage, sports-related injuries, and road accidents represents one of the primary factors supporting the market growth. Moreover, the expanding geriatric population that is more susceptible to developing this condition is leading to a higher demand for foot drop implants across the globe. Additionally, there has been a significant shift toward minimally invasive (MI) surgical procedures for foot drop treatment as they offer a shorter recovery period, less scarring and incision, and reduced risk of complications. In line with this, the growing utilization of surgical foot drop implants to provide direct mechanical support and restore muscle function has accelerated product adoption rates. Furthermore, the leading manufacturers are focusing on the launch of novel implant variants that offer better stability, support, comfort, and ease of use. Such product innovations are improving patient outcomes and satisfaction, thereby propelling market growth. Besides this, the easy availability of favorable reimbursement policies and the escalating demand for personalized treatment options are augmenting market growth. Other factors, including the rising incidences of neurological disorders, improving medical infrastructure, increasing healthcare expenditure, technological advancements in implant design and materials, and ongoing research and development (R&D) activities, are also anticipated to fuel market growth in the coming years.
IMARC Group provides an analysis of the key trends in each segment of the global foot drop implants market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product and end user.
Functional Electrical Stimulators
Internal Fixation Devices
The report has provided a detailed breakup and analysis of the foot drop implants market based on the product. This includes functional electrical stimulators and internal fixation devices. According to the report, internal fixation devices represented the largest segment.
Hospitals
Palliative Care Centers
Orthopedic Centers
Others
A detailed breakup and analysis of the foot drop implants market based on the end user has also been provided in the report. This includes hospitals, palliative care centers, orthopedic centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for foot drop implants. Some of the factors driving the North America foot drop implants market included the growing burden of neurological conditions, rapidly aging population, continuous technological advancements and product launches by key players, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global foot drop implants market. Detailed profiles of all major companies have been provided. Some of the companies covered include aap Implantate AG, Acumed LLC (Colson Medical LLC), Arthrex Inc., Bioness Inc. (Bioventus Inc.), Narang Medical Limited, Ottobock SE & Co. KGaA, Stryker Corporation, Zimmer Biomet, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.